Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Innoviva, Inc.(INVA) | 2,816,022 | 2,816,022 | 0 | $51.05M | $56.57M | 36.64% | +$5.52M |
| Neurocrine Biosciences, Inc.(NBIX) | 309,116 | 303,151 | -5,965 | $34.19M | $38.10M | 24.68% | +$3.91M |
| Amarin Corp PlcADR | 0 | 1,242,527 | +1,242,527 | $0 | $20.15M | 13.05% | +$20.15M |
| Cytokinetics, Incorporated(CYTK) | 600,000 | 588,357 | -11,643 | $24.11M | $19.44M | 12.59% | -$4.67M |
| Ironwood Pharmaceuticals, Inc.CL A(IRWD) | 16,390,000 | 15,919,435 | -470,565 | $24.09M | $11.42M | 7.40% | -$12.68M |
| Lantheus Holdings, Inc.(LNTH) | 100,000 | 96,251 | -3,749 | $9.76M | $7.88M | 5.10% | -$1.88M |
| Vor Biopharma Inc.(VOR) | 508,016 | 508,016 | 0 | $364.5K | $823.0K | 0.53% | +$458.5K |
| Amarin Corp PlcADR | 24,850,623 | 0 | -24,850,623 | $11.14M | $0 | — | -$11.14M |